EMA Authorised: Insulin aspart Sanofi (insulin aspart) — Sanofi Winthrop Industrie

View source ↗

Summary

The European Medicines Agency authorised Sanofi Winthrop Industrie's insulin aspart for the treatment of diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin aspart Sanofi (insulin aspart)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Sanofi Winthrop Industrie. Decision date: 05/02/2026